Eva Yin joined BeiGene in January 2022 as CCO, Greater China. Ms. Yin has 20+ years of experience in the pharmaceutical industry, with various roles in finance, HR, compliance, commercial & channel, market access, key account, retail, broad market, oncology business, and overseas assignments. She has gained deep insights into the evolving landscape and characteristics of the healthcare industry.

Prior to BeiGene, Ms. Yin worked at AstraZeneca for 15+ years, during which she held various positions including commercial & channel VP, GM of HK & Macau, GM of Oncology China, etc. In 2010, She was appointed to work overseas in the Philippines and later in Europe. In 2015, she built up businesses including retail, broad market (county), and community healthcare center committee, from scratch. In 2017, she was transferred to HK to lead HK& Macau business and relocated back to Shanghai in 2018 as GM of oncology business China. Ms. Yin also served at ELI LILLY.

Ms. Yin graduated from Shanghai Jiao Tong University with double majors in finance & trading, and computer science. She obtained her full-time MBA from China Europe International Business School and completed an exchange program at London Business School in 2002.